Proposed Data Collection Submitted for Public Comment and Recommendations, 9320-9321 [2018-04330]
Download as PDF
<![CDATA[
9320
Federal Register / Vol. 83, No. 43 / Monday, March 5, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Total
burden
hours
Type of respondent
Form name
Site data manager ............................
Study participant ...............................
Study participant ...............................
Form 1—Questionnaire ....................
Form 1—Questionnaire ....................
Smartphone survey ..........................
3
720
720
5
5
52
10
1.5
2/60
150
5,400
1,248
Total ...........................................
...........................................................
........................
........................
........................
6,828
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04329 Filed 3–2–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Centers for Disease Control and
Prevention
[60Day–18–0571; Docket No. CDC–2018–
0017]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Minimum Data Elements (MDEs)
for the National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP).’’
DATES: CDC must receive written
comments on or before May 4, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0017 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:25 Mar 02, 2018
Jkt 244001
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Minimum Data Elements (MDEs) for
the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)—
(OMB Control Number 0920–0571, exp.
12/31/2018)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC)
Background and Brief Description
CDC seeks to request a three-year
OMB approval to revise the information
collection project approved under OMB
Control number 0920–0571. Based on
feedback from grantees and internal
subject matter experts, CDC proposes
use of revised minimum data elements
(MDEs), which decrease the estimated
annualized time burden.
Both breast and cervical cancers are
prevalent among U.S. women. In 2014,
more than 236,000 women were
diagnosed with breast cancer, and more
than 12,000 women were diagnosed
with cervical cancer. Evidence shows
that deaths from both breast and
cervical cancers can be avoided by
increasing women screening services
(mammography and Pap tests).
However, women who are under- or
uninsured, have no regular source of
healthcare, and/or have recently
immigrated to the U.S. typically
underutilize screening services.
Congress passed the Breast and
Cervical Cancer Mortality Prevention
Act of 1990, which directed CDC to
establish the National Breast and
Cervical Cancer Early Detection
Program (NBCCEDP). The purpose of
E:\FR\FM\05MRN1.SGM
05MRN1
9321
Federal Register / Vol. 83, No. 43 / Monday, March 5, 2018 / Notices
the NBCCEDP is to increase breast and
cervical cancer screening rates among
priority populations by funding grantees
to provide breast and cervical cancer
screening services to eligible women.
The NBCCEDP funds 70 grantees
including state health departments and
the District of Columbia, universities,
and tribes or tribal organizations.
Priority populations for the NBCCEDP
include women residing within defined
geographical locations (as determined
by the funded program) who are (1) at
or below 250% of the federal poverty
level, (2) aged 40–64 years for breast
cancer services, and aged 21–64 years
for cervical cancer services, and (3)
under- or uninsured.
CDC issued a new funding
opportunity announcement to support a
(6) timeliness of services; and (7) patient
navigation.
Redesigned data elements will enable
CDC to better gauge progress in meeting
clinical service delivery processes and
patient-level outcomes. Findings will
allow CDC to assess program progress in
meeting goals and monitor
implementation activities, evaluate
outcomes, and identify grantee technical
assistance needs. In addition, data
collected will inform program
improvement and help identify
successful activities that need to be
maintained, replicated, or expanded.
The total estimated annualized
burden hours will decrease from 536 to
350 hours. There are no costs to
respondents other than their time.
5-year cooperative agreement under
CDC–RFA–DP17–1701. The number of
grantees will increase from 67 grantees
to 70 grantees. The current program
includes a stronger focus on grantees
partnering with health systems to
increase breast and cervical cancer
screening rates.
CDC proposes a revision to the MDEs
to include removal of several data
variables that are no longer relevant for
CDC analyses, as well as collapsing/
revising several data variables to reduce
burden and increase clarity for
respondents. The MDEs focus on the
following areas: (1) Patient
demographics; (2) breast cancer
screening; (3) cervical cancer screening;
(4) breast and cervical cancer diagnoses;
(5) breast and cervical cancer treatment;
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total
burden
(in hours)
Type of respondent
Form name
NBCCEDP Grantees .........................
MDEs ................................................
70
2
2.50
350
Total ...........................................
...........................................................
........................
........................
........................
350
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04330 Filed 3–2–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Study of We Grow Together:
The Q–CCIIT Professional Development
System.
OMB No.: New Collection.
Description: The Administration for
Children and Families (ACF) at the U.S.
Department of Health and Human
Services (HHS) seeks approval to
conduct a field test of We Grow
Together, a system of professional
development supports including webbased resources and exercises to be used
by caregivers/teachers, with the help of
professional development providers, to
improve the quality of infant and
toddler care. The study team has
developed We Grow Together: The
Q–CCIIT Professional Development
System based on the research literature
to support caregiver-child interactions
in care settings serving infants and
toddlers. This field test is designed to
(1) examine changes associated with use
of the We Grow Together system and (2)
examine implementation and
participant experiences with the We
Grow Together system. As a secondary
goal, ACF will also further evaluate the
properties of the Q–CCIIT observational
measure. Ultimately, findings from the
field test will provide information about
the experiences of professional
development providers (PD providers)
and caregivers with the We Grow
Together system so that ACF can
improve the system to make the
resources as accessible as possible for
infant-toddler caregivers.
Prior to using the We Grow Together
system, PD providers will complete a
web-based training survey and all
participants will complete a web-based
background survey. Periodically during
the field test, website users will be
asked at log-on to respond to a series of
web-based questions. After system
implementation, participants will
complete a web-based feedback survey.
The study team will also collect
classroom rosters from caregivers before
and after the field test.
Respondents: Early care and
education (ECE) setting representatives
(e.g., directors or owners), caregivers
(center-based and family child care
settings), and professional development
providers (e.g., coaches).
sradovich on DSK3GMQ082PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Total/annual
number of
respondents
Instrument
ECE setting eligibility screener ........................................................................
Caregiver background survey ..........................................................................
PD provider background survey ......................................................................
Caregiver We Grow Together website user data pop-up questions ...............
PD provider We Grow Together website user pop-up questions ...................
Caregiver feedback survey ..............................................................................
VerDate Sep<11>2014
19:25 Mar 02, 2018
Jkt 244001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
745
300
175
300
175
300
E:\FR\FM\05MRN1.SGM
1
1
1
6
5
1
05MRN1
Average
burden hours
per response
.25
.75
.50
.17
.10
1.0
Annual
burden
hours
186
225
88
306
88
300
]]>Agencies
[Federal Register Volume 83, Number 43 (Monday, March 5, 2018)]
[Notices]
[Pages 9320-9321]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-0571; Docket No. CDC-2018-0017]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Minimum Data Elements (MDEs)
for the National Breast and Cervical Cancer Early Detection Program
(NBCCEDP).''
DATES: CDC must receive written comments on or before May 4, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0017 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Minimum Data Elements (MDEs) for the National Breast and Cervical
Cancer Early Detection Program (NBCCEDP)--(OMB Control Number 0920-
0571, exp. 12/31/2018)--Revision--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC)
Background and Brief Description
CDC seeks to request a three-year OMB approval to revise the
information collection project approved under OMB Control number 0920-
0571. Based on feedback from grantees and internal subject matter
experts, CDC proposes use of revised minimum data elements (MDEs),
which decrease the estimated annualized time burden.
Both breast and cervical cancers are prevalent among U.S. women. In
2014, more than 236,000 women were diagnosed with breast cancer, and
more than 12,000 women were diagnosed with cervical cancer. Evidence
shows that deaths from both breast and cervical cancers can be avoided
by increasing women screening services (mammography and Pap tests).
However, women who are under- or uninsured, have no regular source of
healthcare, and/or have recently immigrated to the U.S. typically
underutilize screening services.
Congress passed the Breast and Cervical Cancer Mortality Prevention
Act of 1990, which directed CDC to establish the National Breast and
Cervical Cancer Early Detection Program (NBCCEDP). The purpose of
[[Page 9321]]
the NBCCEDP is to increase breast and cervical cancer screening rates
among priority populations by funding grantees to provide breast and
cervical cancer screening services to eligible women. The NBCCEDP funds
70 grantees including state health departments and the District of
Columbia, universities, and tribes or tribal organizations.
Priority populations for the NBCCEDP include women residing within
defined geographical locations (as determined by the funded program)
who are (1) at or below 250% of the federal poverty level, (2) aged 40-
64 years for breast cancer services, and aged 21-64 years for cervical
cancer services, and (3) under- or uninsured.
CDC issued a new funding opportunity announcement to support a 5-
year cooperative agreement under CDC-RFA-DP17-1701. The number of
grantees will increase from 67 grantees to 70 grantees. The current
program includes a stronger focus on grantees partnering with health
systems to increase breast and cervical cancer screening rates.
CDC proposes a revision to the MDEs to include removal of several
data variables that are no longer relevant for CDC analyses, as well as
collapsing/revising several data variables to reduce burden and
increase clarity for respondents. The MDEs focus on the following
areas: (1) Patient demographics; (2) breast cancer screening; (3)
cervical cancer screening; (4) breast and cervical cancer diagnoses;
(5) breast and cervical cancer treatment; (6) timeliness of services;
and (7) patient navigation.
Redesigned data elements will enable CDC to better gauge progress
in meeting clinical service delivery processes and patient-level
outcomes. Findings will allow CDC to assess program progress in meeting
goals and monitor implementation activities, evaluate outcomes, and
identify grantee technical assistance needs. In addition, data
collected will inform program improvement and help identify successful
activities that need to be maintained, replicated, or expanded.
The total estimated annualized burden hours will decrease from 536
to 350 hours. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees.............. MDEs............ 70 2 2.50 350
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 350
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-04330 Filed 3-2-18; 8:45 am]
BILLING CODE 4163-18-P
